Thekkelnaycke M Rajendiran
Overview
Explore the profile of Thekkelnaycke M Rajendiran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
2609
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Afshinnia F, Rajendiran T, Byun J, Arnipalli M, Rehaume L, Cross J, et al.
Kidney Int Rep
. 2024 Aug;
9(8):2559-2562.
PMID: 39156147
No abstract available.
2.
Choi E, Rajendiran T, Soni T, Park J, Aring L, Muraleedharan C, et al.
Nat Commun
. 2024 Jun;
15(1):4775.
PMID: 38839750
The metal ion transporter SLC39A8 is associated with physiological traits and diseases, including blood manganese (Mn) levels and inflammatory bowel diseases (IBD). The mechanisms by which SLC39A8 controls Mn homeostasis...
3.
Fleischman J, Casey J, Meijer J, Treutelaar M, Rajendiran T, Soni T, et al.
Biochim Biophys Acta Mol Cell Biol Lipids
. 2024 Jan;
1869(3):159451.
PMID: 38191091
Objective: Individuals with higher intrinsic cardiorespiratory fitness (CRF) experience decreased rates of cardiometabolic disease and mortality, and high CRF is associated with increased utilization of fatty acids (FAs) for energy....
4.
Kayampilly P, Roeser N, Rajendiran T, Pennathur S, Afshinnia F
Metabolites
. 2022 Oct;
12(10).
PMID: 36295842
The effect of glycemic stress on de novo lipogenesis (DNL) in podocytes and tubular epithelial cells is understudied. This study is aimed (A) to show the effect of glycemic stress...
5.
Afshinnia F, Reynolds E, Rajendiran T, Soni T, Byun J, Savelieff M, et al.
Ann Clin Transl Neurol
. 2022 Aug;
9(9):1392-1404.
PMID: 35923113
Objective: The serum lipidomic profile associated with neuropathy in type 2 diabetes is not well understood. Obesity and dyslipidemia are known neuropathy risk factors, suggesting lipid profiles early during type...
6.
Ravindran A, Piyarathna D, Gohlke J, Putluri V, Soni T, Lloyd S, et al.
Metabolites
. 2022 Jan;
12(1).
PMID: 35050130
African-American (AA) men are more than twice as likely to die of prostate cancer (PCa) than European American (EA) men. Previous in silico analysis revealed enrichment of altered lipid metabolic...
7.
Fort P, Rajendiran T, Soni T, Byun J, Shan Y, Looker H, et al.
JCI Insight
. 2021 Aug;
6(19).
PMID: 34437304
BACKGROUNDThis study systematically investigated circulating and retinal tissue lipid determinants of human diabetic retinopathy (DR) to identify underlying lipid alterations associated with severity of DR.METHODSRetinal tissues were retrieved from postmortem...
8.
Afshinnia F, Rajendiran T, He C, Byun J, Montemayor D, Darshi M, et al.
Diabetes Care
. 2021 Jul;
44(9):2098-2106.
PMID: 34244329
Objectives: Patients with type 1 diabetes (T1D) exhibit modest lipid abnormalities as measured by traditional metrics. This study aimed to identify lipidomic predictors of rapid decline of kidney function in...
9.
Sas K, Lin J, Wang C, Zhang H, Saha J, Rajendiran T, et al.
Metabolomics
. 2021 Jul;
17(7):65.
PMID: 34219205
Objective: Dyslipidemia is a significant risk factor for progression of diabetic kidney disease (DKD). Determining the changes in individual lipids and lipid networks across a spectrum of DKD severity may...
10.
Konje V, Rajendiran T, Bellovich K, Gadegbeku C, Gipson D, Afshinnia F, et al.
Clin Kidney J
. 2021 Jun;
14(4):1097-1105.
PMID: 34094518
Background: Non-traditional risk factors like inflammation and oxidative stress play an essential role in the increased cardiovascular disease (CVD) risk prevalent in chronic kidney disease (CKD). Tryptophan catabolism by the...